Equity · Healthcare
ACLX
NMSArcellx (ACLX)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for ACLX to draw a line in its place.
Have Arcellx (ACLX) insiders bought or sold shares recently?
ACLX has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 28 April 2026.
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 27 Feb 2026 | Elghandour RamiSEE REMARKS | Sell | 89,916 | 10.2M USD |
| 25 Feb 2026 | Gilson MichelleCHIEF FINANCIAL OFFICER | Sell | 11,219 | 1.3M USD |
| 19 Feb 2026 | Gilson MichelleCHIEF FINANCIAL OFFICER | Sell | 8,384 | 573K USD |
| 17 Feb 2026 | Gilson MichelleCHIEF FINANCIAL OFFICER | Sell | 11,291 | 785K USD |
| 20 Jan 2026 | Lubner David CharlesDirector | Sell | 6,000 | 450K USD |
| 14 Jan 2026 | Heery ChristopherCHIEF MEDICAL OFFICER | Sell | 5,882 | 403K USD |
| 13 Jan 2026 | Heery ChristopherCHIEF MEDICAL OFFICER | Sell | 7,437 | 487K USD |
| 12 Jan 2026 | Heery ChristopherCHIEF MEDICAL OFFICER | Sell | 6,131 | 393K USD |
| 17 Nov 2025 | Heery ChristopherCHIEF MEDICAL OFFICER | Sell | 340 | 31K USD |
| 15 Oct 2025 | Gilson MichelleCHIEF FINANCIAL OFFICER | Sell | 5,364 | 488K USD |
| 06 Oct 2025 | Gilson MichelleCHIEF FINANCIAL OFFICER | Sell | 1,064 | 92K USD |
| 03 Oct 2025 | Gilson MichelleCHIEF FINANCIAL OFFICER | Sell | 4,882 | 420K USD |
| Sold | 12 open-market sales | 157,910 | $15.64M |
22 other filings: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 28 Apr 2026 | Galligan Andrew HDirector | Other | 5,000 | |
| 28 Apr 2026 | Lubner David CharlesDirector | Other | 21,659 | |
| 28 Apr 2026 | Elghandour RamiSEE REMARKS | Other | 692,551 | |
| 28 Apr 2026 | Heery ChristopherCHIEF MEDICAL OFFICER | Other | 23,749 | |
| 28 Apr 2026 | Gilson MichelleCHIEF FINANCIAL OFFICER | Other | 72,048 | |
| 28 Apr 2026 | Carroll JillDirector | Other | 1,479,148 | |
| 28 Apr 2026 | Behbahani AliDirector | Other | 4,631 | |
| 16 Apr 2026 | Gilson MichelleCHIEF FINANCIAL OFFICER | Option exercise | 2,110 | 18K USD |
| 15 Apr 2026 | Gilson MichelleCHIEF FINANCIAL OFFICER | Option exercise | 36,000 | 312K USD |
| 17 Mar 2026 | Gilson MichelleCHIEF FINANCIAL OFFICER | Gift | 5,000 | |
| 04 Mar 2026 | Elghandour RamiSEE REMARKS | Gift | 101,164 | |
| 11 Feb 2026 | Elghandour RamiSEE REMARKS | Gift | 416,500 |
Showing the 12 most recent of 22 compensation filings in this window. The figures above count all of them.
Which funds hold Arcellx (ACLX)?
0 of the 45 institutional funds we track reported a Arcellx position for the quarter ended 30 Jun 2026; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Balyasny Asset Management | Exited | |||
| Citadel Advisors | Exited | |||
| Man Group | Exited | |||
| Millennium Management | Exited | |||
| Point72 Asset Management | Exited | |||
| Renaissance Technologies | Exited | |||
| Soros Fund Management | Exited | |||
| Tudor Investment Corp | Exited |
What has been filed or recorded for Arcellx (ACLX)?
The filings we hold for Arcellx, newest first: 6 quarterly earnings reports and 2 annual reports, the latest dated 31 Dec 2025. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −4.07 USD | Revenue $22M |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.99 USD | Revenue $5M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.94 USD | Revenue $8M |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −1.13 USD | Revenue $8M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −2.00 USD | Revenue $108M |
| 30 Sep 2024 | Quarterly earnings | Q3 2024 reported | EPS −0.48 USD | Revenue $26M |
| 30 Jun 2024 | Quarterly earnings | Q2 2024 reported | EPS −0.51 USD | Revenue $27M |
| 31 Mar 2024 | Quarterly earnings | Q1 2024 reported | EPS −0.14 USD | Revenue $39M |
Arcellx (ACLX): frequently asked questions
Have Arcellx insiders bought or sold shares recently?
No Arcellx insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 28 Apr 2026 (SEC Form 4). See Insiders
Which funds own Arcellx?
0 of the 45 funds we track reported a Arcellx position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Balyasny Asset Management, Citadel Advisors and Man Group. See Funds
When did Arcellx last report earnings?
Arcellx last reported earnings on 31 Dec 2025 for FY 2025, with EPS of −4.07 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SEC EDGARXBRL company facts
- SEC EDGARreported earnings figures and scheduled report dates